Vanguard Global Advisers’s AngioDynamics ANGO Stock Holding History

Vanguard Global Advisers’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Hold	17,418	–	–	﹤0.01%	2453
2026 Q1	$198K	Buy	+17,418	New	+$189K	﹤0.01%	2442

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's ANGO Position: Q2 2026 in Review

Vanguard Global Advisers held its AngioDynamics (ANGO) position steady in Q2 2026 at 17,418 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Vanguard Global Advisers first reported a position in ANGO in Q1 2026 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Vanguard Global Advisers held 17,418 shares of AngioDynamics worth $227K as of Q2 2026.
Vanguard Global Advisers left its AngioDynamics share count unchanged in Q2 2026.
AngioDynamics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2453 holding.
Vanguard Global Advisers first reported a position in AngioDynamics in Q1 2026 and has held it in 2 quarters since.
160 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.